The COVID-19 Vaccine Race: Intellectual Property, Collaboration(s), Nationalism and Misinformation

Abstract

The COVID-19 pandemic has brought a national and global vaccine race. This Article examines the race with respect to contemporary frameworks for biopharmaceutical research and development. Specifically, this Article focuses on the effect of patents, pre-production agreements, public-private partnerships, and vaccine misinformation. This Article analyzes lessons learned from the COVID-19 pandemic, advocates for promoting vaccine affordability and equity, and suggests modifications to existing preparedness frameworks to prepare for upcoming outbreaks of infectious disease.

Keywords

COVID, COVID-19, coronavirus, coronavirus pandemic, pandemic, intellectual property, IP, patent, patents, vaccine

Share

Authors

Ana Santos Rutschman (Saint Louis University School of Law)

Download

Issue

Publication details

Dates

Licence

All rights reserved

File Checksums (MD5)

  • pdf: e215bcec734759513b45381a87577bcd